fibrosis Blade Therapeutics

Blade Therapeutics starts Phase l trial of BLD-2660 for fibrosis

Blade Therapeutics has commenced a Phase l clinical trial to investigate the safety and pharmacokinetics (PK) of BLD-2660 for the…